In both human chronic lymphocytic leukemia (CLL) and the New Zealand Black (NZB) murine model of CLL, decreased levels of microRNAs miR-15a/16 play an important role in the disease. Here we investigate the effects of this microRNA on early steps of B cell development and the capacity of miR-15a-deficient hematopoietic stem cells (HSC) and B1 progenitor cells (B1P) to reproduce CLL-like phenotype both in vitro and in vivo. Our results demonstrate that both miR-15a deficient HSC and B1P cells are capable of repopulating irradiated recipients and produce higher numbers of B1 cells than sources with normal miR-15a/16 levels. Furthermore, induced pluripotent stem (iPS) cells derived for the first time from NZB mice, provided insights into the B cell differentiation roadblock inherent in this strain. In addition, exogenously delivered miR-15a into the NZB derived B cell line provided valuable clues into novel targets such as Mmp10 and Mt2. Our data supports the hypothesis that miR-15a/16 deficient stem cells and B1Ps experience a maturation blockage, which contributes to B1 cells bias in development. This work will help understand the role of miR-15a in early events of CLL and points to B1P cells as potential cells of origin for this incurable disease.
Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia
Chingiz Underbayev,S. Kasar,William Ruezinsky,Heba A Degheidy,Joel S. Schneider,G. Marti,S. Bauer,D. Fraidenraich,M. Lightfoote,V. Parashar,E. Raveche,M. Batish
Published 2016 in OncoTarget
ABSTRACT
PUBLICATION RECORD
- Publication year
2016
- Venue
OncoTarget
- Publication date
2016-08-14
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-44 of 44 references · Page 1 of 1
CITED BY
Showing 1-16 of 16 citing papers · Page 1 of 1